Publications
Deboo A. Numbness and Paresthesias in the Elderly. Geriatrics and Aging 2003; 6:11-15.
Gordon P, Moore D, Miller R, Florence J, et al for the Western ALS Study Group. Efficacy of Minocycline in Patients with Amyotrophic Lateral Sclerosis: a phase III randomised trial. Lancet Neurol. 2007;6(12):1045-1053.
Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial. Kaufmann P, Levy G, Montes J, et al for the QALS study group. Amyotrophic Lateral Sclerosis; 2007:8(1):42-46.
Kaufmann P, Thompson J, Levy G, et al and the QALS Study Group. Phase II Trial of CoQ10 in ALS Finds Insufficient Evidence to Justify Phase III. Ann Neurol. 2009;66(2):235-44.
Buchsbaum R, Kaufmann P, Barsdorf AI, and the QALS Study Group. Web-based data management for a phase II clinical trial in ALS. Amyotroph Lateral Scler. 2009:10(5-6):374-7.
Aggarwal S, Zinman L, Simpson E, McKinley J, et al. Safety and Efficacy of Lithium in Combination with Riluzole for Treatment of Amyotrophic Lateral Sclerosis: a Randomised, Double-blind, Placebo-controlled Trial. Lancet Neurol. 2010;9(5):481-8.
Sanders DB, Rosenfeld J, Dimachkie MM, Meng L, Malik F for the Tirasemtiv in Myasthenia Gravis Study Group. A Double-Blinded, Randomized, Placebo-Controlled Trial to Evaluate Efficacy, Safety, and Tolerability of Single Doses of Tirasemtiv in Patients with Acetylcholine Receptor-Binding Antibody-Positive Myasthenia Gravis. Neurotherapeutics. 2015 Apr;12(2):455-60.
Dey S, Roshal D, Rojas L, Schwartzman R, Deboo A, Heiman-Patterson T. Intravenous Lidocaine as a Treatment for Refractory Myotonia Congenita. Drexel Med Journal. 2016: 10(1): 54-58.
Deboo A, Heiman-Patterson TD. Amyotrophic lateral sclerosis. In: Textbook of Internal Medicine - An Intensive Board Review with 1000 MCQs. Baliga RR (ed). Blendon-Miller 2015 (in press).
Heiman-Patterson TD, Pillai A, Deboo A, Sherman M. Standard equations are Poor Predictors of Caloric Expenditure in Patients with Amyotrophic Lateral Sclerosis. 55th Annual Meeting of the American Academy of Neurology; 2003:P01.158.
Hyman BA, Sherman M, Deboo A, Mitchell M, Carlson D, Heiman-Patterson T. Positional Changes in Forced Vital Capacity in Bulbar vs Non-Bulbar ALS Patients. 15th International Symposium on ALS/MND; 2004: P118.
Heiman-Patterson T, Deboo A, Saadiq R, Sebestian J, Joseph K, Sherman M. Substrate Utilization in Hypermetabolic Amyotrophic Lateral Sclerosis (ALS) Patients. 59th Annual Meeting of the American Academy of Neurology; 2007:P01.088.
Russo G, Chen J, Saadiq R, Barr C, Deboo A, Heiman-Patterson T. Non-invasive Measurement of Mouth to Colon Transit Time in Patients with Amyotrophic Lateral Sclerosis (ALS). 19th International Symposium on ALS/MND; 2008:P170.
King J, Feldman S, Heiman-Patterson T, Deboo A, Vaughan T, Sellers E, Wolpaw J. An EEG Impedance Correlation Study for Brain Computer Interface. 19th International Symposium on ALS/MND; 2008:P215.
Nieves C, Eppig J, Libon D, Harris D, Feldman S, Paolone M, Rojas L, Deboo A, Heiman-Patterson T. Forced Vital Capacity, Bulbar Onset, and Neuropsychological Impairment in Amyotrophic lateral sclerosis (ALS). Neurology 2012; 78(suppl 1):P04.231.
Harris D, Eppig J, Nieves C, Paolone M, Deboo A, Heiman-Patterson T. Forced Vital Capacity, Neuropsychological Impairment, and Amyotrophic Lateral Sclerosis. 23rd International Symposium on ALS/MND; 2012:P210.
Amerstein M, Deboo A, Heiman-Patterson T, Harris D. Barriers to PEG Tube Placement in Patients with ALS and the Effect of Video-Based Education on Their Perceptions and Choices. 23rd International Symposium on ALS/MND; 2012:CW301.
Heiman-Patterson T, Wicas G, Eppig, J, Nieves C, Harris D, Paolone M, Deboo A, Libon D. Comparison of Cognitive Changes in Primary Lateral Sclerosis and Amyotrophic Lateral Sclerosis using the Philadelphia Brief Assessment of Cognition (PBAC) Testing Paradigm. Northeast ALS Consortium (NEALS) Meeting 2012.
Scull L, Ayaz H, Shewokis P, Libon D, Wicas G, Eppig J, Feldman S, Deboo A, Heiman-Patterson T. Use of FNIR to Examine Hemodynamic Changes During Cognitive Tasks in Individuals with ALS. 24th International Symposium on ALS/MND; 2013:P63.
Libon D, Heiman-Patterson T, Lippa C, Wicas G, Eppig J, Scull L, Deboo A. Cross-Sectional and Longitudinal Neuropsychological Assessment in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis. Neurology 2013;80(meeting abstracts):P07.166.
Fayyaz T, Edwards J, Scull L, Ayaz H, Shewokis P, Libon D, Deboo A, Heiman-Patterson, T. Cortical Hemodynamics Assessment in ALS During Cognitive Testing Using Functional Near Infrared Spectroscopy (fNIR). 66th Annual Meeting of the American Academy of Neurology; 2014:P4.100
Dey S, Roshal D, Rojas L, Schwartzman R, Deboo A, Heiman-Patterson T. Assessment of 2 Patients with Myotonia Congenita Following Intravenous Lidocaine Treatment. 66th Annual Meeting of the American Academy of Neurology; 2014:P7.095.
Edwards J, Fayyaz T, Scull L, Ayaz H, Shewokis P, Libon D, Lippa C, Deboo A, Heiman-Patterson, T. Functional Near-Infrared Spectroscopy (fNIR) based Detection of increased Prefrontal Cortex Activity in Frontotemporal Dementia. 66th Annual Meeting of the American Academy of Neurology; 2014:P3.217.
Heiman-Patterson T, Dey S, Alexander G, Deboo A. Application of a Staging System to the ProAct Database Population. 25th International Symposium on ALS/MND; 20014:P143.
Patient Comments